- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Zoetis Inc (ZOE)
| Open: | 25.215 | Day's Range: | 25.215 - 25.785 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 25.436 | 52wk Range: | 22.370 - 27.300 | 1-Yr Rtn: | - |
Key Statistics for ZOE
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 23.7940 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 1.4000 |
| Est. PEG Ratio | 1.8735 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 151 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 0.77% |
| Cash Dividend (USD) | 0.0650 |
| Last Dividend | 04/29/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ZOE
Company Profile & Key Executives for ZOE
Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.
| Juan Ramon AlaixChief Executive Officer | Kristin C PeckExec VP/Group President |
| Richard A PassovExec VP/CFO | Roxanne LaganoExec VP/Chief Human Resources |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ZOE News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page